货号: CL-0360
Price: ¥1400 ¥1400
生长培养基: MEM(含NEAA)[PM150410]+10% FBS[164210]+1% P/S[PB180120]
产品信息
产品名称 | HOS(人骨肉瘤细胞) |
生长特性 | 贴壁细胞 |
细胞形态 | 成纤维细胞、上皮细胞样 |
冻存条件 |
冻存液:55% 基础培养基+40% FBS+5% DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:MEM(含NEAA)[PM150410]+10% FBS[164210]+1% P/S[PB180120] 培养条件: 气相:空气,95%;CO₂,5%, 温度:37℃ |
培养方案B(可选) |
生长培养基: 培养条件: 气相:, 温度:37℃ |
推荐传代比例 | 1:2-1:4 |
推荐换液频率 | 2-3次/周 |
参考资料(来源文献)
背景描述 | HOS细胞是从一名13岁的白人女性的骨肉瘤组织中分离建立的;HOS细胞表现为扁平形态、低饱和密度、软琼脂中的低克隆形成率和对化合物及病毒感染的敏感性。 |
年龄(性别) | 13Y Female |
组织来源 | 骨;骨肉瘤 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 肉瘤细胞 |
生物安全等级 | BSL-1 |
STR位点信息
STR鉴定图
-
Exploring the immune microenvironment of osteosarcoma through T cell exhaustion-associated gene expression: a study on prognosis prediction(2023)
作者:Junchao Zhu, Jinghong Yuan, Shahrzad Arya, Zhi Du, Xijuan Liu, Jingyu Jia
期刊:Frontiers in Immunology
DOI:10.3389/fimmu.2023.1265098
影响因子:7.3
-
A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes(2023)
作者:Haijun Tang, Shangyu Liu, Xiaoting Luo, Yu Sun, Xiangde Li, Kai Luo, Shijie Liao, Feicui Li, Jiming Liang, Xinli Zhan, Qingjun Wei, Yun Liu, Maolin He
期刊:Frontiers in Immunology
DOI:10.3389/fimmu.2023.1150588
影响因子:7.3
引用产品: 143B 细胞, HOS 细胞
-
A1BG-AS1 promotes the biological functions of osteosarcoma cells via regulating the microRNA-148a-3p/USP22 axis and stabilizing the expression of SIRT1 through deubiquitinase function(2023)
作者:Xiuxin Han, Mengfan Yin, Chen Gong, Chao Zhang, Genbao Zhu, Mengxue Hu, Kemeng Tan, La Jiang, Guowen Wang, Lili Li
期刊:EXPERT OPINION ON THERAPEUTIC TARGETS
DOI:10.1080/14728222.2023.2263908
影响因子:5.8
引用产品: U-2 OS [U2OS] 细胞, Saos-2 细胞, MG-63 细胞, HOS 细胞, SJSA-1 细胞, hFOB 1.19 细胞, McCoy's 5A 培养基, MEM 培养基, RPMI-1640 培养基, DMEM/F12 培养基
-
Solasonine Inhibits Cancer Stemness and Metastasis by Modulating Glucose Metabolism via Wnt/β-Catenin/Snail Pathway in Osteosarcoma(2023)
作者:Bangjun Wang, Yi Zhou, Peng Zhang, Jun Li, Xinyan Lu
期刊:AMERICAN JOURNAL OF CHINESE MEDICINE
影响因子:5.7
引用产品: HOS 细胞, U-2 OS [U2OS] 细胞
-
Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma(2023)
作者:Zhao Zhang, Zhijie Zhu, Jun Fu, Xincheng Liu, Zhenzhou Mi, Huiren Tao, Hongbin Fan
期刊:INTERNATIONAL IMMUNOPHARMACOLOGY
DOI:10.1016/j.intimp.2023.109684
影响因子:5.6
-
ATRX loss suppresses the type I interferon response in sarcoma cells through chromatin remodeling(2023)
作者:Xinrui Wang, Zige Jin, Shanshan Tang, Xiyu Huang, Shanshan Wang, Xiaohe Ren, Mafei Xu
期刊:American Journal of Cancer Research
DOI:PMID:37693131
影响因子:5.3
引用产品: HOS 细胞, U-2 OS [U2OS] 细胞, Saos-2 细胞, 293T [HEK-293T] 细胞, MG-63 细胞
-
Circular RNA hsa_circ_001350 contributes to osteosarcoma progression by regulating microRNA-578/CCR4-NOT transcription complex and subunit 7/Wnt signaling(2023)
作者:Rujin Xu, Xingyuan Ci, Fang He, Yueqin Chen
期刊:American Journal of Cancer Research
DOI:PMID:37424831
影响因子:5.3
引用产品: hFOB 1.19 细胞, U-2 OS [U2OS] 细胞, HOS 细胞, Saos-2 细胞, MG-63 细胞
-
HTRA3 transcriptionally inhibited by FOXP1 suppresses tumorigenesis of osteosarcoma via the PTEN/PI3K/AKT pathway(2023)
作者:Ziyuan Tong, Yuan Shen, Quan Yuan, Honghao Yu
期刊:BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
DOI:10.1016/j.bbamcr.2023.119553
影响因子:5.1
引用产品: HOS 细胞, Saos-2 细胞, SW 1353 细胞, McCoy's 5A 培养基
-
Sulfatinib, a novel multi-targeted tyrosine kinase inhibitor of FGFR1, CSF1R, and VEGFR1–3, suppresses osteosarcoma proliferation and invasion via dual role in tumor cells and tumor microenvironment(2023)
作者:Liao Song, Li Jianxiong, Gao Song, Han Yuchen, Han Xinli, Wu Yanan, Bi Jingyou, Xu Meng, Bi Wenzhi
期刊:Frontiers in Oncology
影响因子:4.7
引用产品: MG-63 细胞, U-2 OS [U2OS] 细胞, HOS 细胞, K7M2 wt [K7M2-WT] 细胞, RAW 264.7 细胞
-
WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner(2023)
作者:Qiyong Pan, Jigang Lou, Penghui Yan, Xiaobiao Kang, Pengfei Li, Zongqiang Huang
期刊:ENVIRONMENTAL TOXICOLOGY
影响因子:4.5
引用产品: DMEM/F12 培养基, 特级胎牛血清, MEM 培养基, hFOB 1.19 细胞, McCoy's 5A 培养基, HOS 细胞, U-2 OS [U2OS] 细胞, 青霉素-链霉素溶液(双抗),100×
-
Q1:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢?
部分细胞是会出现多种培养条件的,我们公司优先选择引种来源的培养条件以及建系者所用培养条件,出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件,为了避免细胞突然更换培养条件后不适应,建议您优先使用厂家推荐的培养条件培养。

识别码示意图